Gelstat Corp
GSAC- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890725
No open-market purchases or sales by Gelstat Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Gelstat Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Gelstat Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Goldfarb Adrian Graham | Director | 87,768,609 | Mar 8, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 (view filing)11:47 AM ET | Feb 4 | 32 daysLate | Goldfarb Adrian GrahamDirector | PPurchaseCommon Stock, par value $0.01 | +87.1M | $0.0045 | +$390.9K | +12,168.5%87.8M after | 4 lots |